These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27695973)

  • 1. Is gastroscopy for fecal immunochemical test positive patients worthwhile?
    Ng JY; Chan DK; Tan KK
    Int J Colorectal Dis; 2017 Jan; 32(1):95-98. PubMed ID: 27695973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroscopy after positive screening for faecal immunochemical tests and colonoscopy: A systematic review.
    Choe L; Lau J; Yip LT; Kim G; Tan KK
    PLoS One; 2023; 18(2):e0281557. PubMed ID: 36763684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.
    Caviglia GP; Cabianca L; Fagoonee S; Gili FM
    Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline.
    Allard J; Cosby R; Del Giudice ME; Irvine EJ; Morgan D; Tinmouth J
    Can J Gastroenterol; 2010 Feb; 24(2):113-20. PubMed ID: 20151070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study.
    Shahidi N; Gentile L; Gondara L; Hamm J; McGahan CE; Enns R; Telford J
    Can J Gastroenterol Hepatol; 2016; 2016():4650471. PubMed ID: 28116286
    [No Abstract]   [Full Text] [Related]  

  • 8. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia.
    Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic upper endoscopy concomitant with colonoscopy performed within the colorectal cancer screening program: Impact on the patients' management.
    Planade O; Dessomme B; Chapelle N; Verdier M; Duchalais E; Queneherve L; Le Rhun M; Coron E; Mosnier JF; Matysiak-Budnik T; Touchefeu Y
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101501. PubMed ID: 33714864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening.
    Grobbee EJ; Kapidzic A; van Vuuren AJ; van Leerdam M; Lansdorp-Vogelaar I; Looman CW; Bruno MJ; Kuipers EJ; Spaander MC
    Am J Gastroenterol; 2015 Jul; 110(7):1072-7. PubMed ID: 26054624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.
    Cubiella J; Salve M; Díaz-Ondina M; Vega P; Alves MT; Iglesias F; Sánchez E; Macía P; Blanco I; Bujanda L; Fernández-Seara J
    Colorectal Dis; 2014 Aug; 16(8):O273-82. PubMed ID: 24456168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.
    Jensen CD; Corley DA; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Zhao WK; Marks AR; Schottinger JE; Ghai NR; Lee AT; Contreras R; Klabunde CN; Quesenberry CP; Levin TR; Mysliwiec PA
    Ann Intern Med; 2016 Apr; 164(7):456-63. PubMed ID: 26811150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
    Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
    Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests.
    Castells A; Quintero E; Álvarez C; Bujanda L; Cubiella J; Salas D; Lanas A; Carballo F; Morillas JD; Hernández C; Jover R; Hijona E; Portillo I; Enríquez-Navascués JM; Hernández V; Martínez-Turnes A; Menéndez-Villalva C; González-Mao C; Sala T; Ponce M; Andrés M; Teruel G; Peris A; Sopeña F; González-Rubio F; Seoane-Urgorri A; Grau J; Serradesanferm A; Pozo À; Pellisé M; Balaguer F; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; de la Vega-Prieto M; Iglesias R; Amador J; Blanco JM; Sastre R; Ferrándiz J; González-Hernández MJ; Andreu M; Bessa X;
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1708-16.e4. PubMed ID: 24681078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
    Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
    Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms.
    Chiang TH; Lee YC; Liao WC; Chung JH; Chiu HM; Tu CH; Chen SC; Wu MS
    PLoS One; 2015; 10(9):e0136890. PubMed ID: 26332318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of One versus Two Fecal Immunochemical Tests in the Detection of Colorectal Neoplasia in a Population-Based Colorectal Cancer Screening Program.
    Moosavi S; Enns R; Gentile L; Gondara L; McGahan C; Telford J
    Can J Gastroenterol Hepatol; 2016; 2016():5914048. PubMed ID: 28044123
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
    Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
    Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.